Health-related quality of life and patient reported outcomes among people living with HIV and cancer

艾滋病毒和癌症患者的健康相关生活质量和患者报告的结果

基本信息

项目摘要

PROJECT SUMMARY Advances in HIV treatment have improved life expectancy among people with HIV (PWH). As PWH live longer, they are at increased risk for cancer and cancer-related mortality compared with the general population. However, it remains unclear what factors may contribute to persistent survival disparities and poor cancer outcomes among PWH in the US. Integrating measurement of patient-reported outcomes (PROs) into routine and supportive cancer care is a potential strategy to improve PWH’s quality of life, cancer outcomes, and survival. PROs encompass data reported directly by patients to describe how they feel and function, such as symptoms, physical function, and health-related quality of life. In the general (i.e., HIV-uninfected) cancer patient population, PRO scores are associated with several adverse cancer clinical outcomes including poor response to therapy, cancer progression, and shorter survival. Given that PWH are also more likely to be diagnosed with non-AIDS defining cancers at later stages and experience elevated mortality, it is urgent to investigate opportunities, such as the role of PROs, to improve survival and ultimately reduce preventable cancer deaths among PWH. However, to our knowledge, no research exists in the context PROs and overall health-related quality of life among PWH with cancer. To address this research gap, our objective is to evaluate physical and mental health symptomology (PROs) throughout the cancer diagnosis trajectory and associations with cancer outcomes among HIV-positive cancer patients. We propose a two-pronged approach: we will leverage an existing, NCI-sponsored, data linkage between the Surveillance, Epidemiology, and End Results (SEER) cancer registry data and Centers for Medicare and Medicaid Services (CMS)’ Medicare Health Outcomes Survey (MHOS) (Aims 1 and 2) and conduct primary data collection among HIV positive cancer patients treated at an NCI-designated cancer center (Aim 3). We will carry out the following specific aims: Aim 1: Compare changes in patient reported outcomes (PROs) after a cancer-diagnosis among non-AIDS defining cancer patients living with and without HIV; Aim 2: Estimate associations of PROs (pre-diagnosis, post-diagnosis, and change in PROs) with overall survival among older patients diagnosed with non-AIDS defining cancers with HIV; and Aim 3: Explore the role of HIV-specific clinical and social factors in patient reported outcome assessments among a broad age range of HIV positive cancer patients treated at one NCI-designated cancer center. Findings from this research will provide preliminary data to inform the development of future large-scale R01-level research opportunities focused on improving symptom control among PWH with cancer and evaluating the integration of tailored patient-reported outcome data collection into routine supportive care of this vulnerable population.
项目摘要 艾滋病毒治疗的进步提高了艾滋病毒感染者的预期寿命。随着威尔斯亲王医院的寿命延长, 与一般人口相比,他们患癌症的风险和与癌症有关的死亡率更高。 然而,目前还不清楚是什么因素可能导致持续的生存差异和癌症 在美国PWH中的结果。将患者报告结局(PRO)的测量纳入常规 支持性癌症护理是改善威尔斯亲王医院生活质量、癌症预后和生存率的潜在策略。 PRO包括患者直接报告的数据,以描述他们的感觉和功能,如症状, 身体功能和健康相关的生活质量。在一般情况下(即,未感染HIV的)癌症患者群体, PRO评分与几种不利的癌症临床结果相关,包括对治疗的不良反应, 癌症进展和更短的生存期。鉴于威尔斯亲王医院的病人被诊断为非爱滋病的机会亦较大, 在晚期阶段定义癌症并经历死亡率升高,迫切需要调查机会, 作为PRO的作用,以提高生存率,并最终减少可预防的癌症死亡在威尔斯亲王医院。然而,在这方面, 据我们所知,目前还没有针对PWH中的PRO和整体健康相关生活质量的研究 得了癌症为了弥补这一研究空白,我们的目标是评估身心健康的生物学 (PRO)在整个癌症诊断轨迹和与艾滋病毒阳性患者的癌症结局的关联 癌症患者。我们提出了一个双管齐下的方法:我们将利用现有的,由国家癌症研究所赞助的,数据链接 监测、流行病学和最终结果(SEER)癌症登记数据与医疗保险中心之间 和医疗补助服务(CMS)的医疗保险健康结果调查(MHOS)(目标1和2),并进行主要 在NCI-designated cancer center接受治疗的HIV阳性癌症患者中收集数据(Aim 3)。我们将 目标1:比较治疗后患者报告结局(PRO)的变化, 非艾滋病定义的癌症患者中的癌症诊断;目标2:估计 PRO(诊断前、诊断后和PRO变化)与老年人总生存率的相关性 目的3:探讨HIV特异性临床诊断的作用, 在广泛年龄范围的HIV阳性癌症患者中,患者报告的结局评估中的社会因素 在一个NCI指定的癌症中心接受治疗的患者。这项研究的结果将提供初步数据 告知未来大规模R 01级研究机会的发展,重点是改善症状 在患有癌症的PWH中进行控制,并评估定制的患者报告结局数据的整合 收集到这些弱势群体的日常支持性护理。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jessica Yasmine Islam其他文献

Jessica Yasmine Islam的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 16.85万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 16.85万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.85万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.85万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 16.85万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.85万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 16.85万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 16.85万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 16.85万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.85万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了